New Developments in Minimally Invasive SurgeryHysteropexy Evidence and InsightsRIDGEWAY, BERI M. MD*; CADISH, LAUREN MD†Author Information *Women's Health Institute, Cleveland Clinic, Cleveland, Ohio †Providence Saint John’s Health Center, Santa Monica, California B.M.R. is a consultant for Coloplast Inc. L.C. declares that there is nothing to disclose. Correspondence: Beri M. Ridgeway, MD, Women's Health Institute, Cleveland Clinic, 9500 Euclid Avenue, A81, Cleveland, OH 44195. E-mail: email@example.com Clinical Obstetrics and Gynecology: June 2017 - Volume 60 - Issue 2 - p 312-323 doi: 10.1097/GRF.0000000000000281 Buy Metrics Abstract Uterovaginal prolapse may be treated with or without concomitant hysterectomy. Many patients express interest in uterine-sparing prolapse procedures, for which there are increasing evidence available regarding techniques and outcomes. Uterine-sparing procedures to treat uterovaginal prolapse require a unique set of surgical considerations including uterine abnormalities, possibility of occult malignancy, and future pregnancy. Data, including randomized controlled trials, support the use of sacrospinous hysteropexy. Other prospective trials detailing outcomes following uterosacral hysteropexy, mesh augmented sacrospinous hysteropexy, and sacrohysteropexy are also encouraging. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.